GlassScriptPhysician profile
Kathy L Summers
NPI 1972505808
$1,292.94
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.38 · 2020: $18.06 · 2021: $134 · 2022: $695 · 2023: $414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $414.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $191.15 | 2021-2022 | |
| Abbvie INC. | $146.30 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $128.56 | 2023 | Myfembree |
| Pfizer INC. | $118.98 | 2021-2023 | |
| Astellas Pharma US INC | $110.50 | 2022-2023 | Veozah, Myrbetriq |
| Organon LLC | $85.33 | 2022-2023 | Nexplanon |
| Agile Therapeutics, INC. | $73.78 | 2022-2023 | Twirla |
| Bayer Healthcare Pharmaceuticals INC. | $55.26 | 2022 | |
| Scynexis, INC. | $49.76 | 2022 | |
| Hologic Sales and Service, LLC | $45.60 | 2021-2023 | Myosure Tissue Removal Device, Fluent Fluid Management System |
| Millicent US INC | $34.93 | 2023 | Intrarosa, Femring |
| Evofem Biosciences, INC. | $32.97 | 2022 | |
| Therapeuticsmd, INC. | $26.63 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $24.18 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $23.21 | 2023 | Vivjoa |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $22.94 | 2023 | |
| Davol INC. | $21.28 | 2021 | |
| Mylan Pharmaceuticals INC. | $20.39 | 2022 | |
| Exeltis, USA INC. | $18.06 | 2020 | |
| Merck Sharp & Dohme LLC | $17.47 | 2019 | |
| Coopersurgical, INC. | $16.28 | 2023 | Paragard T 380a |
| Avion Pharmaceuticals | $15.10 | 2023 | Balcoltra |
| Aspira Women'S Health INC | $14.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathy Summers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.